FDA May Refuse Imports of Chinese Drug Manuf. for CGMP, Labeling, Registration Violations
The Food and Drug Administration detailed a laundry list of violations by drug manufacturer Shanghai Huhui Daily Use Chemical Products Co., in a warning letter sent Nov. 14. Specific violations included violations of current good manufacturing practice regulations, and misbranded…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
over the counter drugs because of incorrect labeling. The company also offered its products for sale in the U.S. from 2009 to 2012 without registering with FDA. Until all violations have been corrected, FDA may refuse imports from the manufacturer, it said.